Literature DB >> 31256221

Characteristic asymmetric limbic and anterior temporal atrophy in demented patients with pathologically confirmed argyrophilic grain disease.

Keita Sakurai1, Aya M Tokumaru2, Toshimasa Ikeda3, Satoru Morimoto4, Shohei Inui5,6, Kaoru Sumida5, Hiroshi Oba5, Motoo Nakagawa7, Noriyuki Matsukawa3, Yoshio Hashizume8.   

Abstract

PURPOSE: The purpose of this study is to clarify the characteristic structural magnetic resonance imaging (MRI) findings in demented patients with pathologically confirmed argyrophilic grain disease (AGD).
METHODS: Nine pathologically confirmed AGD patients with cerebral three-dimensional T1-weighted MRI were evaluated in this study. In addition to visual rating scales of atrophic and asymmetric changes in the limbic and temporal lobes, voxel-based morphometry (VBM) was performed to assess group difference between pathologically confirmed AGD and Alzheimer's disease (AD) patients.
RESULTS: On visual analyses of AGD patients, the medial temporal, anterior temporal, and posterior temporal atrophy scores were 3.3 ± 0.7, 1.7 ± 0.5, and 1.0 ± 0.7, respectively. Asymmetric scores of the hippocampus and parahippocampal gyrus, amygdala and ambient gyrus, anterior temporal, and posterior temporal lobes were rated as 1.1 ± 0.7, 1.6 ± 0.5, 1.3 ± 0.8, and 0.4 ± 0.7, respectively. In spite of no statistical differences in atrophic scores, AGD patients showed the higher score and proportion of anterior temporal asymmetric score than AD (p = 0.03 and 0.02). Compared with controls, VBM analysis revealed left dominant asymmetric atrophy predominantly in the limbic and anterior temporal lobe in AGD patients. By contrast, there was no significant gray matter reduction between AGD and AD patients.
CONCLUSIONS: Asymmetric atrophy relatively localized to the anterior temporal and limbic lobes including the amygdala and ambient gyrus is a characteristic MRI finding of AGD. For the precise antemortem diagnosis, especially to differentiation from AD, it is important to pay attention to this asymmetric change.

Entities:  

Keywords:  Argyrophilic grain disease; Asymmetric atrophy; Magnetic resonance imaging; Visual rating scale; Voxel-based morphometry

Year:  2019        PMID: 31256221     DOI: 10.1007/s00234-019-02247-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  34 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Imaging correlates of pathology in corticobasal syndrome.

Authors:  J L Whitwell; C R Jack; B F Boeve; J E Parisi; J E Ahlskog; D A Drubach; M L Senjem; D S Knopman; R C Petersen; D W Dickson; K A Josephs
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

Review 3.  Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.

Authors:  Lorna Harper; Frederik Barkhof; Nick C Fox; Jonathan M Schott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-14       Impact factor: 10.154

4.  Argyrophilic grains: a distinct disease or an additive pathology?

Authors:  Keith A Josephs; Jennifer L Whitwell; Joseph E Parisi; David S Knopman; Bradley F Boeve; Yonas E Geda; Clifford R Jack; Ronald C Petersen; Dennis W Dickson
Journal:  Neurobiol Aging       Date:  2006-12-26       Impact factor: 4.673

5.  Mitochondrial dysfunction and oxidative and endoplasmic reticulum stress in argyrophilic grain disease.

Authors:  Ekaterina V Ilieva; Anton Kichev; Alba Naudí; Isidre Ferrer; Reinald Pamplona; Manuel Portero-Otín
Journal:  J Neuropathol Exp Neurol       Date:  2011-04       Impact factor: 3.685

6.  Clinical aspects of argyrophilic grain disease.

Authors:  K Ikeda; H Akiyama; T Arai; M Matsushita; K Tsuchiya; H Miyazaki
Journal:  Clin Neuropathol       Date:  2000 Nov-Dec       Impact factor: 1.368

7.  Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Authors:  M-Marsel Mesulam; Sandra Weintraub; Emily J Rogalski; Christina Wieneke; Changiz Geula; Eileen H Bigio
Journal:  Brain       Date:  2014-02-25       Impact factor: 13.501

8.  Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

Authors:  I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1996-01       Impact factor: 3.685

9.  Argyrophilic grain disease: frequency and neuropathology in centenarians.

Authors:  Zheng-Tong Ding; Yin Wang; Yu-Ping Jiang; Mari Yoshida; Maya Mimuro; Toshiaki Inagaki; Tamaki Iwase; Yoshio Hashizume
Journal:  Acta Neuropathol       Date:  2006-03-09       Impact factor: 17.088

Review 10.  Argyrophilic grain disease: An underestimated tauopathy.

Authors:  Roberta Diehl Rodriguez; Lea Tenenholz Grinberg
Journal:  Dement Neuropsychol       Date:  2015 Jan-Mar
View more
  3 in total

1.  Clinicoradiological Features in Progressive Supranuclear Palsy Comorbid with Argyrophilic Grains.

Authors:  Keita Sakurai; Daita Kaneda; Satoru Morimoto; Yuto Uchida; Shohei Inui; Yasuyuki Kimura; Takashi Kato; Kengo Ito; Yoshio Hashizume
Journal:  Mov Disord Clin Pract       Date:  2022-05-02

2.  Voxel-Based Morphometry Analysis of Structural MRI for Differentiation Between Dementia with Lewy Bodies and Alzheimer's Disease [Letter].

Authors:  Shohei Inui; Keita Sakurai; Yoshio Hashizume
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-16       Impact factor: 2.570

Review 3.  Tauopathies: new perspectives and challenges.

Authors:  Yi Zhang; Kai-Min Wu; Liu Yang; Qiang Dong; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2022-04-07       Impact factor: 14.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.